Cervical cancer is a very high reproductive malignancy in women. One of the treatments to deal with the malignancy becoming severe is chemotherapy. Nausea and vomiting are signs of the most frequent symptoms caused by chemotherapy. Autogenic therapy is one of the nonpharmacological solutions to treat nausea and vomiting due to chemotherapists. This study aims to determine the effectiveness of autogenic therapy to reduce symptoms of nausea and vomiting post-chemotherapy among patients with cervical cancer. A quasi-experimental method with a pretest-posttest design was conducted postchemotherapy on 40 patients of stage II and III cervical cancer. The research instrument used was the observation sheet for the assessment of nauseous vomit, namely the NRS assessment. Demographic data revealed that the majority of patients were aged 46-55 years (40%), their education level was high school (40%) and they had undergone chemotherapy more than once (35%). The results showed that autogenic therapy significantly reduced nausea and vomiting in cervical cancer patients after chemotherapy (P value = 0.001). Based on the results of pretest and posttest observations, autogenic therapy can be used as a non-pharmacological treatment to reduce symptoms of nausea and vomiting post-chemotherapy in cervical cancer patients. Autogenic therapy is recommended to reduce the symptoms of nausea and vomiting in post-chemotherapy of cervical cancer patients.
 Keywords: autogenic therapy, chemotherapy, nausea and vomiting